Early brain metastasis of advanced gastric cancer with a pathological complete response to neoadjuvant chemotherapy followed by surgery: A case report and literature review

References

• Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–32. doi:10.3322/caac.21338. PMID:26808342.
   PubMed Web of Science ®Google Scholar
• Yu M, Zheng HC, Xia P, Takahashi H, Masuda S, Takano Y, Xu HM. Comparison in pathological behaviours & prognosis of gastric cancers from general hospitals between China & Japan. Indian J Med Res. 2010;132:295–302. PMID:20847376.
   PubMed Web of Science ®Google Scholar
• Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20. doi:10.1056/NEJMoa055531. PMID:16822992.
   PubMed Web of Science ®Google Scholar
• Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, Ducourtieux M, Bedenne L, Fabre JM, Saint-Aubert B, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29:1715–21. doi:10.1200/JCO.2010.33.0597. PMID:21444866.
   PubMed Web of Science ®Google Scholar
• Cho H, Nakamura J, Asaumi Y, Yabusaki H, Sakon M, Takasu N, Kobayashi T, Aoki T, Shiraishi O, Kishimoto H, et al. Long-term survival outcomes of advanced gastric cancer patients who achieved a pathological complete response with neoadjuvant chemotherapy: a systematic review of the literature. Ann Surg Oncol. 2015;22:787–92. doi:10.1245/s10434-014-4084-9. PMID:25223927.
   PubMedGoogle Scholar
• Deng J, Liang H, Wang D, Sun D, Pan Y, Liu Y. Investigation of the recurrence patterns of gastric cancer following a curative resection. Surg Today. 2011;41:210–5. doi:10.1007/s00595-009-4251-y. PMID:21264756.
   PubMed Web of Science ®Google Scholar
• York JE, Stringer J, Ajani JA, Wildrick DM, Gokaslan ZL. Gastric cancer and metastasis to the brain. Ann Surg Oncol. 1999;6:771–6. doi:10.1007/s10434-999-0771-3. PMID:10622506.
   PubMed Web of Science ®Google Scholar
• Go PH, Klaassen Z, Meadows MC, Chamberlain RS. Gastrointestinal cancer and brain metastasis: a rare and ominous sign. Cancer. 2011;117:3630–40. doi:10.1002/cncr.25940. PMID:21319152.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health, National Cancer Institute, US Department of Health and Human Services. Handbook of Common Terminology Criteria for Adverse Events (CTCAE), Version 4.0. Bethesda (MD): NIH Publication. 2009.
   Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47. doi:10.1016/j.ejca.2008.10.026. PMID:19097774.
   PubMed Web of Science ®Google Scholar
• Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, et al. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016;14:1286–312. doi:10.6004/jnccn.2016.0137. PMID:27697982.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen RX, Zhang J, Cai J, Meng H, Wu GC, Zhang ZT, Wang Y, Wang KL. Efficacy and safety of neoadjuvant chemotherapy with modified FOLFOX7 regimen on the treatment of advanced gastric cancer. Chin Med J (Engl). 2012;125:2144–50. PMID:22884144.
   PubMed Web of Science ®Google Scholar
• Li ZY, Koh CE, Bu ZD, Wu AW, Zhang LH, Wu XJ, Wu Q, Zong XL, Ren H, Tang L, et al. Neoadjuvant chemotherapy with FOLFOX: improved outcomes in Chinese patients with locally advanced gastric cancer. J Surg Oncol. 2012;105:793–9. doi:10.1002/jso.23009. PMID:22189752.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhao L, Liu H, Zhong D, Liu W, Shan G, Dong F, Gao W, Bai C, Li X. A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer. Br J Cancer. 2016;114:1326–33. doi:10.1038/bjc.2016.126. PMID:27172250.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yu YY, Li W, Feng Y, Hou J, Ji Y, Sun YH, Shen KT, Shen ZB, Qin XY, et al. A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis. Cancer Chemother Pharmacol. 2014;73:1155–61. doi:10.1007/s00280-014-2449-1. PMID:24748418.
   PubMed Web of Science ®Google Scholar
• Jary M, Ghiringhelli F, Jacquin M, Fein F, Nguyen T, Cleau D, Nerich V, El Gani M, Mathieu P, Valmary-Degano S, et al. Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer. Cancer Chemother Pharmacol. 2014;74:141–50. doi:10.1007/s00280-014-2482-0. PMID:24824852.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Tanabe K, Nishikawa K, Ito Y, Matsui T, Kimura Y, Hasegawa S, Aoyama T, Hayashi T, Morita S, et al. Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study. Ann Surg Oncol. 2014;21(Suppl 3):S385–389. doi:10.1245/s10434-014-3615-8. PMID:24595801.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Peng Z, Chen L. Survival analysis of gastric cancer cases with pathological complete response received neoadjuvant chemotherapy. Zhonghua Yi Xue Za Zhi. 2016;96:1582–4. PMID:27266687.
   PubMedGoogle Scholar
• Kasakura Y, Fujii M, Mochizuki F, Suzuki T, Takahashi T. Clinicopathological study of brain metastasis in gastric cancer patients. Surg Today. 2000;30:485–90. doi:10.1007/s005950070112. PMID:10883456.
   PubMed Web of Science ®Google Scholar
• Fields RC, Strong VE, Gonen M, Goodman KA, Rizk NP, Kelsen DP, Ilson DH, Tang LH, Brennan MF, Coit DG, et al. Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. Br J Cancer. 2011;104:1840–7. doi:10.1038/bjc.2011.175. PMID:21610705.
   PubMed Web of Science ®Google Scholar
• Chabner BALD. Cancer chemotherapy and biotherapy: principles and practice. Philadelphia (PA): Lippincott Williams & Wilkins; 2011.
   Google Scholar
• He HJ, Wang Y, Le Y, Duan KM, Yan XB, Liao Q, Liao Y, Tong JB, Terrando N, Ouyang W. Surgery upregulates high mobility group box-1 and disrupts the blood-brain barrier causing cognitive dysfunction in aged rats. CNS Neurosci Ther. 2012;18:994–1002. doi:10.1111/cns.12018. PMID:23078219.
   PubMed Web of Science ®Google Scholar
• Sakurai K, Muguruma K, Murata A, Toyokawa T, Amano R, Kubo N, Tanaka H, Yashiro M, Maeda K, Ohira M, et al. Early gastric cancer with suspected brain metastasis arising eight y after curative resection: a case report. BMC Res Notes. 2014;7:818. doi:10.1186/1756-0500-7-818. PMID:25411022.
   PubMedGoogle Scholar
• Matsunaga M, Wada S, Daa T, Harada K, Okamura K, Noguchi T. Long-term survival after resection of brain metastases from esophagogastric junction adenocarcinoma: report of two cases and review of the literature. Clin J Gastroenterol. 2014;7:213–8. doi:10.1007/s12328-014-0491-5. PMID:26183738.
   PubMedGoogle Scholar
• Bartelt S, Momm F, Weissenberger C, Lutterbach J. Patients with brain metastases from gastrointestinal tract cancer treated with whole brain radiation therapy: prognostic factors and survival. World J Gastroenterol. 2004;10:3345–8. doi:10.3748/wjg.v10.i22.3345. PMID:15484315.
   PubMed Web of Science ®Google Scholar